Financial support for TECENTRIQ® (atezolizumab) Financial support for TECENTRIQ® (atezolizumab)

FINANCIAL RESOURCES

To help you find the right patient assistance option for you, we've created the Patient Assistance Tool. Just enter some simple information to find out which service you're eligible for.

  • Are you insured?

  • Do you have commercial health insurance?

    What does this mean?
  • Are you already getting financial assistance to help pay for your medicine?

    What does this mean?
  • Are you over 18 years of age?

Genentech BioOncology Co-pay Card

This program might be able to help with the out-of-pocket costs of your medicine.

 

Click here to learn more about the Genentech BioOncology Co-pay Card.

Independent Co-pay Assistance Foundations

If you need help with medication co-pays, we can refer you to independent co-pay assistance foundations. Foundations have their own specific criteria.

 

Click here to learn more about independent co-pay assistance foundations.

The Genentech® Access to Care Foundation, or GATCF

GATCF helps qualified patients receive their medicine free of charge. To qualify for free medicine from GATCF, you need to meet specific criteria.

 

Click here to learn more about GATCF.

TECENTRIQ® Access Solutions

TECENTRIQ Access Solutions is a resource for people who take TECENTRIQ. We do all we can to connect you to the medicine you need.

Learn more at Genentech-Access.com/TECENTRIQ

Genentech® Access to Care Foundation (GATCF)

You may also be eligible for the Genentech® Access to Care Foundation (GATCF), which helps people who have health insurance and those who don’t. If you qualify for GATCF, you could receive TECENTRIQ free of charge.

Learn more about these resources here.


Genentech BioOncology™ Co-pay Card Program

Genentech offers the Genentech BioOncology Co-pay Card Program to help you with the out-of-pocket (OOP) costs of TECENTRIQ. The Co-pay card is not health insurance or a benefit plan.

The Co-pay card is available to you or your loved one if you are 18 years or older and covered by commercial (also known as private) insurance. You or your loved one must also live and receive treatment in the United States or Puerto Rico, be receiving TECENTRIQ for an FDA-approved indication, and not be receiving assistance through the Genentech® Access to Care Foundation or any other co-pay charitable organization.

Click here to learn more about the Genentech BioOncology Co-pay Card.

INDICATION

TECENTRIQ is a prescription medicine used to treat a type of lung cancer called non-small cell lung cancer (NSCLC). TECENTRIQ may be used when your lung cancer:

  • Has spread or grown, and
  • You have tried chemotherapy that contains platinum, and it did not work or is no longer working

If your tumor has an abnormal EGFR or ALK gene, you should have also tried an FDA-approved therapy for tumors with these abnormal genes, and it did not work or is no longer working.

It is not known if TECENTRIQ is safe and effective in children.

IMPORTANT SAFETY INFORMATION

What is the most important information about TECENTRIQ?
TECENTRIQ can cause your immune system to attack normal organs and tissues in many areas of your body and can affect the way they work. These problems can sometimes become serious or life threatening and can lead to death.

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may delay or completely stop treatment with TECENTRIQ if you have severe side effects.

Call or see your healthcare provider right away if you get any symptoms of the following problems or these symptoms get worse.

TECENTRIQ can cause serious side effects, including:

  • Lung problems (pneumonitis)–signs and symptoms may include new or worsening cough, shortness of breath, and chest pain
  • Liver problems (hepatitis)–signs and symptoms of hepatitis may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), drowsiness, dark urine (tea colored), bleeding or bruising more easily than normal, and feeling less hungry than usual
  • Intestinal problems (colitis)–signs and symptoms of colitis may include diarrhea (loose stools) or more bowel movements than usual, blood in your stools or dark, tarry, sticky stools, and severe stomach area (abdomen) pain or tenderness
  • Hormone gland problems (especially the pituitary, thyroid, adrenal glands, and pancreas)–signs and symptoms that your hormone glands are not working properly may include headaches that will not go away or unusual headaches, extreme tiredness, weight gain or weight loss, dizziness or fainting, feeling more hungry or thirsty than usual, hair loss, changes in mood or behavior (such as decreased sex drive, irritability, or forgetfulness), feeling cold, constipation, your voice gets deeper, urinating more often than usual, nausea or vomiting, and stomach area (abdomen) pain
  • Nervous system problems (neuropathy, meningitis, encephalitis)–signs and symptoms of nervous system problems may include severe muscle weakness, numbness or tingling in hands and feet, fever, confusion, changes in mood or behavior, extreme sensitivity to light, and neck stiffness
  • Inflammation of the eyes–signs and symptoms may include blurry vision, double vision, or other vision problems, and eye pain or redness
  • Severe infections–signs and symptoms of infection may include fever, cough, frequent urination, flu-like symptoms, and pain when urinating
  • Severe infusion reactions–signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, fever, feeling like passing out, back or neck pain, and swelling of your face or lips

Before you receive TECENTRIQ, tell your healthcare provider about all your medical conditions, including if you:

  • Have immune system problems (such as Crohn’s disease, ulcerative colitis, or lupus); have had an organ transplant; have lung or breathing problems; have liver problems; have a condition that affects your nervous system (such as myasthenia gravis or Guillain-Barré syndrome); or are being treated for an infection
  • Are pregnant or plan to become pregnant
    • TECENTRIQ can harm your unborn baby
    • If you are able to become pregnant, you should use an effective method of birth control during your treatment and for at least 5 months after the last dose of TECENTRIQ
  • Are breastfeeding or plan to breastfeed
    • It is not known if TECENTRIQ passes into your breast milk
    • Do not breastfeed during treatment and for at least 5 months after the last dose of TECENTRIQ

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of TECENTRIQ in people with non-small cell lung cancer include:

  • Feeling tired
  • Decreased appetite
  • Shortness of breath
  • Cough
  • Nausea
  • Muscle or bone pain
  • Constipation

TECENTRIQ may cause fertility problems in females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of TECENTRIQ. Ask your healthcare provider or pharmacist for more information.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information.